These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 12052711)

  • 1. Chemo-Enzymatic PEGylation/POxylation of Murine Interleukin-4.
    Haas D; Hauptstein N; Dirauf M; Driessen MD; Ruopp M; Schubert US; Lühmann T; Meinel L
    Bioconjug Chem; 2022 Jan; 33(1):97-104. PubMed ID: 34967625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Study of PEG Linkers That Enable Robust Characterization of PEGylated Proteins.
    Saha-Shah A; Sun S; Kong J; Zhong W; Mann BF
    ACS Pharmacol Transl Sci; 2021 Aug; 4(4):1280-1286. PubMed ID: 34423265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Synthesis to Characterization of Site-Selective PEGylated Proteins.
    Belén LH; Rangel-Yagui CO; Beltrán Lissabet JF; Effer B; Lee-Estevez M; Pessoa A; Castillo RL; Farías JG
    Front Pharmacol; 2019; 10():1450. PubMed ID: 31920645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-selective protein conjugation at histidine.
    Peciak K; Laurine E; Tommasi R; Choi JW; Brocchini S
    Chem Sci; 2019 Jan; 10(2):427-439. PubMed ID: 30809337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalysis by Transglutaminases: A Review of Biotechnological Applications.
    Savoca MP; Tonoli E; Atobatele AG; Verderio EAM
    Micromachines (Basel); 2018 Oct; 9(11):. PubMed ID: 30715061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes.
    Selis F; Schrepfer R; Sanna R; Scaramuzza S; Tonon G; Dedoni S; Onali P; Orsini G; Genovese S
    Results Pharma Sci; 2012; 2():58-65. PubMed ID: 25755995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate PEGylation, an approach to improve pharmacological potency.
    Giorgi ME; Agusti R; de Lederkremer RM
    Beilstein J Org Chem; 2014; 10():1433-44. PubMed ID: 24991298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agile delivery of protein therapeutics to CNS.
    Yi X; Manickam DS; Brynskikh A; Kabanov AV
    J Control Release; 2014 Sep; 190():637-63. PubMed ID: 24956489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable gel graft for bone defect repair.
    Fang J; Yang Z; Tan S; Tayag C; Nimni ME; Urata M; Han B
    Regen Med; 2014 Jan; 9(1):41-51. PubMed ID: 24351005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain delivery of proteins via their fatty acid and block copolymer modifications.
    Yi X; Kabanov AV
    J Drug Target; 2013 Dec; 21(10):940-55. PubMed ID: 24160902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic PEGylation.
    Tada S; Andou T; Suzuki T; Dohmae N; Kobatake E; Ito Y
    PLoS One; 2012; 7(11):e49235. PubMed ID: 23145132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uricases as therapeutic agents to treat refractory gout: Current states and future directions.
    Yang X; Yuan Y; Zhan CG; Liao F
    Drug Dev Res; 2012 Mar; 73(2):66-72. PubMed ID: 22665944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein- and peptide-modified synthetic polymeric biomaterials.
    Krishna OD; Kiick KL
    Biopolymers; 2010; 94(1):32-48. PubMed ID: 20091878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of therapeutic proteins.
    Pisal DS; Kosloski MP; Balu-Iyer SV
    J Pharm Sci; 2010 Jun; 99(6):2557-75. PubMed ID: 20049941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.
    Parveen S; Sahoo SK
    Clin Pharmacokinet; 2006; 45(10):965-88. PubMed ID: 16984211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific labeling of proteins for single-molecule FRET by combining chemical and enzymatic modification.
    Jäger M; Nir E; Weiss S
    Protein Sci; 2006 Mar; 15(3):640-6. PubMed ID: 16452617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic procedure for site-specific pegylation of proteins.
    Sato H
    Adv Drug Deliv Rev; 2002 Jun; 54(4):487-504. PubMed ID: 12052711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2.
    Sato H; Yamamoto K; Hayashi E; Takahara Y
    Bioconjug Chem; 2000; 11(4):502-9. PubMed ID: 10898571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase.
    Sato H; Ikeda M; Suzuki K; Hirayama K
    Biochemistry; 1996 Oct; 35(40):13072-80. PubMed ID: 8855943
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.